![]() |
市场调查报告书
商品编码
1843565
2025年全球医疗诊断人工智慧市场报告AI In Medical Diagnostics Global Market Report 2025 |
||||||
近年来,人工智慧在医疗诊断领域的市场规模迅速扩张,从2024年的19.2亿美元成长到2025年的26.6亿美元,复合年增长率达38.3%。预测期内的成长归因于健康意识的提高、慢性病盛行率的上升、老龄化人口的扩大、对天然产品需求的增加以及机能性食品和饮料的扩张。
预计未来几年,人工智慧在医疗诊断领域的市场将呈指数级增长,到2029年市场规模将达到104.2亿美元,复合年增长率高达40.7%。预测期内的成长主要归因于人们对免疫健康的日益关注、对植物来源产品需求的不断增长、美容和化妆品行业的扩张、营养保健品和功能性补充剂市场的增长,以及全球永续性和伦理规范的推行。预测期内的关键趋势包括:消费者对机能性食品的认知度和需求不断提高、营养保健品和膳食补充剂应用范围的扩大、对天然和植物来源来源的关注、提取和加工技术的创新,以及健康生活方式的兴起。
人工智慧在医学诊断中的应用 将人工智慧应用于治疗和医学诊断领域,用于分析X光、MRI、超音波、 电脑断层扫描和DXA等医学影像数据,旨在帮助医生更准确、更快速地检测和诊断疾病。
人工智慧在医疗诊断领域的主要组成部分是软体和服务。医疗诊断软体能够影像处理,检测各种指标,例如细胞内异常增殖的分子,这些分子代表疾病。这个过程涉及的技术包括自然语言处理、电脑视觉、机器学习和情境感知计算。这些技术应用于神经病学、肿瘤学、心血管病学、胸肺病学以及妇产科等专科诊断领域。它们透过电脑辅助检测、电脑辅助诊断、定量分析工具和临床决策支援系统等方式应用,并被医院、影像中心、诊断实验室和其他医疗营业单位广泛使用。
美国在2025年春季突然提高关税及其引发的贸易摩擦,对资讯科技产业,特别是硬体製造、资料基础设施和软体部署领域,产生了重大影响。进口半导体、电路基板和网路设备的关税上涨,推高了高科技公司、云端服务供应商和资料中心的生产和营运成本。在全球范围内采购笔记型电脑、伺服器和消费电子产品零件的公司,面临更长的前置作业时间和价格压力。同时,对专用软体征收的关税以及主要国际市场的报復性措施,扰乱了全球IT供应链,并降低了海外对美国製造技术的需求。为了应对这些挑战,该产业正在加大对国内晶片生产的投资,扩大供应商网络,并利用人工智慧驱动的自动化技术来增强韧性,更有效地控製成本。
本研究报告是商业研究公司(The Business Research Company)最新系列报告的一部分,提供关于人工智慧在医疗诊断领域应用的市场统计数据,包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和商业机会,为您提供在人工智慧医疗诊断行业取得成功所需的全部数据。这份人工智慧医疗诊断市场研究报告全面概述了您所需的一切信息,并对该行业的现状和未来发展趋势进行了深入分析。
未来五年40.7%的预测成长率较我们先前对该市场的预测略微下降了0.6%。这一下降主要归因于美国与其他国家之间的关税影响。这可能会直接影响美国,因为依赖日本和荷兰影像感测器的AI诊断工具成本将会增加,从而限制疾病的早期检测。此外,由于相互关税以及贸易紧张局势和限制措施升级对全球经济和贸易造成的负面影响,这种影响也将更加广泛。
医疗保健领域投资的成长预计将推动人工智慧在医疗诊断市场的未来发展。医疗保健支出是指公共部门和私部门用于医疗保健服务的总收入比例。这项投资透过为医疗保健专业人员创造就业机会、增加其收入、提高地方政府税收以及创造对相关产品和服务的需求,支持人工智慧技术在医疗保健领域的应用。例如,根据总部位于加拿大的非营利组织加拿大健康资讯研究所2023年11月发布的报告,预计2023年医疗保健总支出将达到3,440亿美元,比前一年略微增加2.8%。因此,医疗保健领域投资的成长是推动人工智慧在医疗诊断市场扩张的关键因素。
预计未来几年,远端保健和远端医疗的兴起将推动人工智慧在医疗诊断领域的市场成长。远端医疗利用通讯技术远端提供广泛的医疗保健服务和讯息,尤其侧重于远距临床咨询和医疗服务。远端医疗透过远端患者监护、虚拟咨询和数位影像分析,提高了远端医疗环境下的诊断效率。它在影像解读、病理分析和分流中发挥关键作用,确保评估的准确性和及时性。此外,预测分析、与穿戴式装置的整合以及可扩展的数据管理进一步增强了人工智慧的能力,提高了偏远和医疗资源匮乏地区的医疗服务可近性和患者疗效。例如,根据美国数位健康机构Rock Health在2023年2月进行的一项调查,80%的受访者在2022年至少使用过一次远端医疗,高于2021年的72%。因此,远端医疗和远距咨询的成长是推动人工智慧在医疗诊断市场扩张的关键因素。
人工智慧在医疗诊断领域的市场正经历以产品创新为特征的显着趋势,领先企业积极推出新的解决方案以巩固其市场地位。 2023年3月,新加坡软体公司Qritive推出了“Qai Prostate”,这是一款专注于前列腺癌诊断的人工智慧工具。这款创新产品能够区分良性和恶性肿瘤,精准定位前列腺癌病灶,并辨识前列腺腺癌。值得一提的是,Qai Prostate工具能够帮助病理学家筛选、优先处理并集中精力于最有价值的病例,从而提高实验室的工作效率。
医疗诊断人工智慧市场的主要企业正策略性地开发医疗影像处理套件,以获得竞争优势。医疗图像涵盖了用于临床分析和介入的体内可视化技术和流程。 2022年10月,美国科技公司Google(Google LLC)发布了医疗影像套件(Medical Imaging Suite),这是一项旨在提升医疗影像资料可近性、互通性和易用性的行业解决方案。该套件利用人工智慧进行影像诊断,支援更快、更准确的诊断,提高医护人员的工作效率,并改善病患预后。该套件包含人工智慧辅助标註工具、基于BigQuery和Looker等工具的高级分析功能、利用Vertex AI加速人工智慧管道开发,以及适用于云端、本地和边缘环境的灵活部署选项。这个全面且适应性强的解决方案能够满足医疗机构不断变化的需求。
2024年10月,总部位于美国的医疗科技公司GE医疗科技以约5,300万美元收购了Intelligent 超音波 Group PLC。此次收购将使GE医疗能够将Intelligent Ultrasound的AI驱动工具整合到其超音波产品中,旨在简化工作流程,减少重复性工作,并简化临床医生的超音波检查。 Intelligent Ultrasound Group PLC是一家总部位于英国的诊断公司,专注于用于医疗诊断的AI主导超音波软体和培训工具。
在人工智慧医疗诊断市场中营运的主要企业包括:国际商业机器公司 (IBM)、西门子医疗股份公司 (Siemens Healthineers AG)、通用电气医疗技术公司 (GE HealthCare Technologies Inc.)、Digital Diagnostics Inc.、Heartflow Inc.、Aidoc Medical Ltd.、皇家飞利浦公司 (Konvidlijke Corporation, Nonvidlike 公司、塔本Corporation)、英特尔公司 (Intel Corporation)、赛灵思公司 (Xilinx Inc)、Enlitic Inc.、Aidence BV、Butterfly Network Inc.、Day Zero Diagnostics Inc.、MicroHealth LLC、Arterys Inc.、PathAI Inc.、Zebra Medical. Medical Inc.、Ultromics Limited、MaxQ AI Ltd. 和 Paige.AI Inc.。
2024年,北美是人工智慧医疗诊断市场最大的区域。预计在预测期内,亚太地区将成为全球人工智慧医疗诊断市场报告中成长最快的区域。此人工智慧医疗诊断市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。
这份人工智慧在医疗诊断的市场报告涵盖以下国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。
医疗诊断人工智慧市场由提供服务的营业单位所获得的收入构成,这些服务包括磁振造影(MRI)、超音波、电脑断层扫描 (CT)、机器人流程自动化 (RPA)、机器学习、自然语言处理和基于规则的专家系统。市场价值还包括服务供应商销售的或包含在其服务产品中的相关商品的价值。医疗诊断人工智慧市场还包括牙科设备、糖尿病护理设备、肾臟/泌尿系统设备、神经科设备以及用于提供医疗诊断人工智慧服务的实体机器人的销售额。该市场的价值为“出厂价”,即商品製造商或生产商销售的商品价值,无论销售对像是其他营业单位(包括下游製造商、批发商、经销商和零售商)还是直接销售给最终客户。该市场中的商品价值还包括商品製造商提供的任何相关服务。
AI in medical diagnostics involves the application of artificial intelligence in the field of treatment and medical diagnostics. It is employed to analyze medical imaging data, including X-rays, MRIs, ultrasounds, CT scans, and DXAs, with the aim of assisting doctors in more precise and rapid disease discovery and diagnosis.
The primary components of AI in medical diagnostics encompass software and services. The software utilized in medical diagnostics can detect various indicators, such as the abnormal proliferation of molecules in cells that may signify a disease, through image processing. Technologies involved in this process include natural language processing, computer vision, machine learning, context-aware computing, and others. These technologies find applications in specialized diagnostic cases, such as brain and neurological, oncology, cardiac and vascular, chest and lung, obstetrics and gynecology, among others. They are applied through computer-aided detection, computer-aided diagnosis, quantitative analysis tools, and clinical decision support systems, and are utilized by hospitals, diagnostic imaging centers, diagnostic laboratories, and other healthcare entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.
The AI in medical diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in medical diagnostics market statistics, including the AI in medical diagnostics industry global market size, regional shares, competitors with an AI in medical diagnostics market share, detailed AI in medical diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in medical diagnostics industry. This AI in medical diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The ai in medical diagnostics market size has grown exponentially in recent years. It will grow from $1.92 billion in 2024 to $2.66 billion in 2025 at a compound annual growth rate (CAGR) of 38.3%. The growth in the historic period can be attributed to health consciousness, rising incidence of chronic diseases, expanding aging population, increased demand for natural products, expansion of functional foods and beverages.
The ai in medical diagnostics market size is expected to see exponential growth in the next few years. It will grow to $10.42 billion in 2029 at a compound annual growth rate (CAGR) of 40.7%. The growth in the forecast period can be attributed to increasing focus on immune health, rising demand for plant-based products, expanding beauty and cosmetics industry, nutraceuticals and functional supplements market growth, global sustainable and ethical practices. Major trends in the forecast period include rising consumer awareness and demand for functional foods, expanding applications in nutraceuticals and dietary supplements, focus on natural and plant-based sources, innovations in extraction and processing technologies, health and wellness as a lifestyle.
The forecast of 40.7% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by increasing expenses for AI-powered diagnostic tools, dependent on imaging sensors from Japan and the Netherlands, limiting early disease detection. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising investment in healthcare is anticipated to drive the growth of the AI market in medical diagnostics in the future. Health expenditure refers to the share of total revenue allocated by both public and private sectors for healthcare services. This investment creates jobs for healthcare professionals, increases earnings for healthcare workers, boosts municipal tax revenues, and generates demand for related goods and services, thereby supporting the application of AI technology in healthcare. For example, the Canadian Institute for Health Information, a non-profit organization based in Canada, reported in November 2023 that total health expenditure is expected to reach $344 billion in 2023, marking a modest increase of 2.8% from the previous year. Thus, the growing investment in healthcare is a key factor driving the expansion of AI in the medical diagnostics market.
The rise in telehealth and telemedicine is expected to drive the growth of the AI market in medical diagnostics in the coming years. Telehealth involves using telecommunications technology to deliver a broad range of healthcare services and information remotely, while telemedicine focuses specifically on remote clinical consultations and healthcare delivery. AI enhances diagnostic efficiency in telehealth environments through remote patient monitoring, virtual consultations, and digital imaging analysis. It plays a crucial role in image interpretation, pathology analysis, and triage, ensuring accurate and timely assessments. Additionally, predictive analytics, integration with wearable devices, and scalable data management further strengthen AI capabilities, improving accessibility and patient outcomes in remote or underserved areas. For instance, a survey conducted by Rock Health, a U.S.-based digital health organization, in February 2023 revealed that 80% of respondents had used telemedicine at least once in 2022, up from 72% in 2021. Therefore, the growth of telehealth and telemedicine is a significant factor driving the expansion of AI in the medical diagnostics market.
The AI in medical diagnostics market is witnessing a significant trend characterized by product innovations, with major companies actively introducing new solutions to maintain their market positions. In March 2023, Qritive, a Singapore-based software company, launched the 'Qai Prostate,' an AI-powered tool specifically designed for prostate cancer diagnosis. This innovative product is capable of distinguishing between benign and malignant tumors, precisely identifying the locations of prostatic cancer, and identifying prostatic adenocarcinoma. Notably, the Qai Prostate tool enhances laboratory productivity by allowing pathologists to select, prioritize, and focus on cases that are most beneficial to them.
Major companies in the AI in medical diagnostics market are strategically developing medical imaging suites to gain a competitive advantage. Medical imaging involves techniques and processes that create visual representations of the interior of the body for clinical analysis and medical intervention. In October 2022, Google LLC, a US-based technology company, introduced the Medical Imaging Suite, an industry solution aimed at improving accessibility, interoperability, and usability of healthcare imaging data. The suite leverages AI for imaging to support faster and more accurate diagnosis, enhance productivity for healthcare workers, and improve patient care outcomes. It includes AI-assisted annotation tools, advanced analytics through tools such as BigQuery and Looker, accelerated AI pipeline development with Vertex AI, and flexible deployment options for cloud, on-premises, or edge settings. This comprehensive and adaptable solution addresses the evolving needs of healthcare organizations.
In October 2024, GE HealthCare Technologies Inc., a medical technology company based in the U.S., acquired Intelligent Ultrasound Group PLC for around $53 million. This acquisition allows GE HealthCare to incorporate Intelligent Ultrasound's AI-driven tools into its ultrasound offerings, aiming to improve workflow efficiency, minimize repetitive tasks, and simplify ultrasound examinations for clinicians. Intelligent Ultrasound Group PLC, a diagnostics company located in the UK, focuses on AI-driven ultrasound software and training tools for medical diagnostics.
Major companies operating in the AI in medical diagnostics market include International Business Machines Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Digital Diagnostics Inc., Heartflow Inc., Aidoc Medical Ltd., Koninklijke Philips N.V., Nanox Imaging Ltd., Microsoft Corporation, Nvidia Corporation, Intel Corporation, Xilinx Inc., Enlitic Inc., Aidence B.V., Butterfly Network Inc., Day Zero Diagnostics Inc., MicroHealth LLC, Arterys Inc., PathAI Inc., Zebra Medical Vision Inc., Tempus Labs Inc., Caption Health Inc., Proscia Inc., AliveCor Corporation, ResApp Health Limited, Volpara Health Technologies Limited, Koios Medical Inc., Ultromics Limited, MaxQ AI Ltd., Paige.AI Inc.
North America was the largest region in the AI in medical diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global AI in medical diagnostics market report during the forecast period. The regions covered in the ai in medical diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the ai in medical diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The AI in medical diagnostics market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), ultrasound, and computed tomography scans, robotic process automation, machine learning, natural language processing, and rule-based expert systems. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in the medical diagnostics market also includes sales of dental devices, diabetes care devices, nephrology and urology devices, neurology devices, and physical robots which are used in providing AI in medical diagnostics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
AI In Medical Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ai in medical diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ai in medical diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in medical diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.